Neonatal jaundice remains a significant problem in new child treatment, impacting up to sixty% of whole-term infants. The need for precise, non-invasive bilirubin measurement has driven healthcare diagnostic devices makers to create State-of-the-art alternatives. Transcutaneous bilirubinometers have emerged being a game-changing tool, allowing heal